Preferred Name |
besifloxacin |
|
Synonyms |
C19H21ClFN3O3 7-[(3R)-3-aminoazepan-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
|
ID |
http://purl.obolibrary.org/obo/dinto_DB06771 |
|
AHFScode |
52:04.04 |
|
ATCCode |
S01AE08 |
|
blocks |
http://purl.obolibrary.org/obo/dinto_0551 http://purl.obolibrary.org/obo/dinto_1417 |
|
CASRN |
141388-76-3 |
|
DBBrand |
besivance |
|
DBSalt |
besifloxacin hydrochloride |
|
DBSynonym |
ss734 bol-303224-a |
|
Definition |
Besifloxacin is a fourth generation fluoroquinolone-type opthalmic antibiotic for the treatment of bacterial conjunctivitis. FDA approved on May 28, 2009. |
|
has pharmacological target |
http://purl.obolibrary.org/obo/dinto_0551 http://purl.obolibrary.org/obo/dinto_1417 |
|
InChI |
InChI=1S/C19H21ClFN3O3/c20-15-16-12(18(25)13(19(26)27)9-24(16)11-4-5-11)7-14(21)17(15)23-6-2-1-3-10(22)8-23/h7,9-11H,1-6,8,22H2,(H,26,27)/t10-/m1/s1 |
|
InChIKey |
InChIKey=QFFGVLORLPOAEC-SNVBAGLBSA-N |
|
label |
besifloxacin |
|
prefixIRI |
obo2:dinto_DB06771 |
|
prefLabel |
besifloxacin |
|
SMILES |
N[C@@H]1CCCCN(C1)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=C1Cl)C(O)=O |
|
Synonym |
C19H21ClFN3O3 7-[(3R)-3-aminoazepan-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
|
xref |
Wikipedia:http://en.wikipedia.org/wiki/Besifloxacin National Drug Code Directory:54868-6282-0 RxList:http://www.rxlist.com/besivance-drug.htm Drugs.com:http://www.drugs.com/besivance.html |
|
subClassOf |